Pa I, R N, R N, Ing B, K T. DIFFERENCE IN BLOOD FUNCTION TOXICITY BETWEEN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS WITH PACLITAXEL CISPLATIN AND PACLITAXEL CARBOPLATIN CHEMOTHERAPY AT SANGLAH HOSPITAL, DENPASAR. Asian J Pharm Clin Res [Internet]. 2018 Jan. 1 [cited 2024 Nov. 4];11(1):224-7. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/22125